{"id":"221614f8-e4a5-4445-a1b6-bbfd4f93ba3f","modelId":"b336d883-18f3-4e77-bb20-bd3e62757e78","versionId":null,"locationId":"ee320ac7-3d14-4a80-bd64-336f2e601f9d","operatorId":"af791bbb-c3b4-4628-bfe7-8404c754dd09","ownerId":null,"slug":"btemia-keeogo-canada-clinical","status":"operational","firstSeen":null,"statusChangeReason":null,"contractType":null,"pilotOutcome":null,"endedAt":null,"unitsOnSite":null,"tasksPerformed":null,"shiftStructure":null,"hoursPerDay":null,"siteType":null,"operatorConfirmed":false,"humanSupervisionOnsite":null,"locationPrecisionTier":null,"deploymentScale":null,"siteEnvironment":null,"operatorType":"maker_operated","sourceQualityTier":null,"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://b-temia.com/","title":"B-TEMIA","date_accessed":"2026-06-07"},{"url":"https://keeogo.com/about-keeogo/clinical-studies","title":"Keeogo Clinical Studies | BTemia","retrievedAt":"2026-06-27T12:00:00Z"},{"url":"https://b-temia.com/home/media-room/b-temias-keeogo-obtains-ce-marking-allowing-its-commercialization-in-eu-countries","title":"B-Temia's Keeogo Obtains CE Marking Allowing Its Commercialization in EU Countries","retrievedAt":"2026-06-27T12:00:00Z"}],"notes":"B-TEMIA Keeogo powered exoskeleton deployed at rehabilitation clinics in Montreal, Canada. FDA-cleared for stroke and MS patients.","keyFacts":[{"label":"Technology","value":"B-TEMIA Keeogo powered exoskeleton"},{"label":"Coverage","value":"Montreal, Canada"},{"label":"Use Case","value":"Rehabilitation clinics for stroke and MS patients"},{"label":"Regulatory","value":"FDA-cleared"}],"reviewNote":null,"exposureHours":null,"deploymentMilesEstimate":null,"exposureBasis":null,"customerSegment":null,"scaleTier":null,"contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-06-07T22:54:24.627Z","updatedAt":"2026-06-28T05:51:22.565Z","model":{"id":"b336d883-18f3-4e77-bb20-bd3e62757e78","companyId":"af791bbb-c3b4-4628-bfe7-8404c754dd09","modelName":"B-TEMIA Keeogo","slug":"btemia-keeogo","description":"Powered (motorized bilateral-knee) wearable exoskeleton for mobility assistance - walking, stairs, sit-to-stand, squatting - for people with stroke, MS, SCI or degenerative conditions. ~5.4 kg with hip battery. CE-marked; sold in Canada, Europe and Asia.","formFactor":"exoskeleton","industryVertical":null,"environment":null,"maturityStage":"commercial","lifecycleState":"active","supersededByModelId":null,"specs":{"use":"medical / personal mobility","control":"AI dermoskeleton (rigid+flexible hybrid)","powered":"yes (motorized knees)","regulatory":"CE-marked","body_region":"bilateral legs (hips/knees)","availability":"commercial"},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://b-temia.com/keeogo/","title":"B-TEMIA Keeogo","sourceName":"B-TEMIA (primary)"},{"url":"https://www.btemia.com/en/keeogo","title":"Keeogo Dermoskeleton","sourceName":"B-Temia"},{"url":"https://b-temia.com/keeogo/","title":"B-TEMIA Keeogo (re-verified primary source)"}],"aliases":["Keeogo","Keeogo+"],"collisionRisk":"low","reviewNote":"reverified 2026-06-09 (Kimi-incident remediation): re-sourced against a current resolving authoritative source (manufacturer/regulator/reputable); relevance confirmed.","manufacturerTermForTeleop":null,"keyFacts":[{"label":"Robot","value":"Keeogo is a motorized bilateral-knee dermoskeleton for mobility assistance."},{"label":"Technology","value":"Dermoskeleton platform"},{"label":"Country","value":"Canada"},{"label":"Product","value":"Keeogo powered walking assist exoskeleton"},{"label":"Partner","value":"Wistron (manufacturing/commercialization in Asia)"}],"createdAt":"2026-06-06T02:05:06.745Z","updatedAt":"2026-07-08T20:01:21.068Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"company":{"id":"af791bbb-c3b4-4628-bfe7-8404c754dd09","name":"B-TEMIA","slug":"b-temia","description":"Canadian bio-robotics company developing Dermoskeleton™ technology for human mobility augmentation. Flagship product Keeogo is a powered exoskeleton for industrial safety, occupational rehabilitation, and medical mobility.","status":"private","founded":2005,"hq":"Quebec City, Canada","fundingTotal":null,"type":"hardware","reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://b-temia.com/keeogo/","title":"B-TEMIA","sourceName":"B-TEMIA (primary)"},{"url":"https://b-temia.com/","title":"B-TEMIA (official)","sourceName":"B-TEMIA (primary)"}],"keyFacts":[{"label":"CEO","value":"Stéphane Bédard (Founder, President & CEO)"},{"label":"HQ","value":"Quebec City, Canada"},{"label":"Founded","value":"2005"},{"label":"Product","value":"Keeogo — powered Dermoskeleton exoskeleton for human mobility augmentation"},{"label":"Funding","value":"~$6.9M reported (late 2018); additional undisclosed funding"},{"label":"Taiwan expansion","value":"B-Temia Asia obtained TFDA product license for commercial access to Taiwan"},{"label":"Incidents","value":"None found — audited"}],"aliases":["B-TEMIA Inc"],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-06T02:05:05.191Z","updatedAt":"2026-07-18T02:05:48.401Z"}},"version":null,"location":{"id":"ee320ac7-3d14-4a80-bd64-336f2e601f9d","name":"Montreal","slug":"montreal-canada","kind":"city","parentLocationId":"615dd675-0877-4ad8-8a92-a98e6bda9f21","region":null,"lat":45.5017,"lng":-73.5673,"reviewStatus":"reviewed","aliases":[],"collisionRisk":"high","reviewNote":null,"createdAt":"2026-06-07T22:54:24.547Z","updatedAt":"2026-07-14T23:12:09.146Z"},"operator":{"id":"af791bbb-c3b4-4628-bfe7-8404c754dd09","name":"B-TEMIA","slug":"b-temia","description":"Canadian bio-robotics company developing Dermoskeleton™ technology for human mobility augmentation. Flagship product Keeogo is a powered exoskeleton for industrial safety, occupational rehabilitation, and medical mobility.","status":"private","founded":2005,"hq":"Quebec City, Canada","fundingTotal":null,"type":"hardware","reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://b-temia.com/keeogo/","title":"B-TEMIA","sourceName":"B-TEMIA (primary)"},{"url":"https://b-temia.com/","title":"B-TEMIA (official)","sourceName":"B-TEMIA (primary)"}],"keyFacts":[{"label":"CEO","value":"Stéphane Bédard (Founder, President & CEO)"},{"label":"HQ","value":"Quebec City, Canada"},{"label":"Founded","value":"2005"},{"label":"Product","value":"Keeogo — powered Dermoskeleton exoskeleton for human mobility augmentation"},{"label":"Funding","value":"~$6.9M reported (late 2018); additional undisclosed funding"},{"label":"Taiwan expansion","value":"B-Temia Asia obtained TFDA product license for commercial access to Taiwan"},{"label":"Incidents","value":"None found — audited"}],"aliases":["B-TEMIA Inc"],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-06T02:05:05.191Z","updatedAt":"2026-07-18T02:05:48.401Z"},"owner":null,"derived":{"trustTier":"unverified","currentPosture":null},"jsonLd":{"@context":"https://schema.org","@type":"Event","@id":"https://registry.deploy.report/deployments/btemia-keeogo-canada-clinical","url":"https://registry.deploy.report/deployments/btemia-keeogo-canada-clinical","name":"B-TEMIA Keeogo at Montreal","identifier":"221614f8-e4a5-4445-a1b6-bbfd4f93ba3f","location":{"@type":"Place","@id":"https://registry.deploy.report/locations/montreal-canada","name":"Montreal"},"organizer":{"@type":"Organization","@id":"https://registry.deploy.report/companies/b-temia","name":"B-TEMIA"},"about":{"@type":"Product","@id":"https://registry.deploy.report/models/btemia-keeogo","name":"B-TEMIA Keeogo"},"publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":"commercial","lifecycle_state":"active","architectural_position":{"cohort":"exoskeleton","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":3,"primary_source_types":[]}}}